Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

5α-reductases increase epitestosterone's effect on androgen receptors.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

Low prolactin in young women may increase heart and metabolism risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Acne and PCOS are linked due to hormonal imbalances and metabolic issues.

PCOS often causes skin problems due to hormonal and metabolic imbalances.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.